ABVC BioPharma
ABVC
ABVC
9 hedge funds and large institutions have $817K invested in ABVC BioPharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
$117K |
| 3 |
TSS
Two Sigma Securities
New York
|
$0 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
$788 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $248K | +$144K | +64,586 | +138% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $246K | +$13.4K | +6,017 | +6% |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $117K | -$17.4K | -7,814 | -13% |
|
4
Renaissance Technologies
New York
| $92.8K | +$92.8K | +41,706 | New |
|
5
Northern Trust
Chicago,
Illinois
| $82.6K | +$40.1K | +18,009 | +94% |
|
6
State Street
Boston,
Massachusetts
| $28.7K | – | – | – |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $1.08K | +$51 | +23 | +5% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $788 | -$4.95K | -2,222 | -86% |
|
9
Bank of America
Charlotte,
North Carolina
| $296 | +$107 | +48 | +56% |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$30.7K | -29,003 | Closed |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$12.2K | -11,470 | Closed |
|